辉瑞等跨国药企加大在中国研发与投资力度,加速本土化创新,中国已成为全球医药大市场,跨国药企看重中国巨大的市场潜力和良好的发展环境,呈现“创新药重仓押注,成熟品战略撤退”态势。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.